scholarly article | Q13442814 |
P356 | DOI | 10.1056/NEJM198212233072601 |
P698 | PubMed publication ID | 6216407 |
P50 | author | Euzenir Nunes Sarno | Q54276613 |
Ralph Steinman | Q105494 | ||
P2093 | author name string | Arrick BA | |
Levis WR | |||
Cohn ZA | |||
Nogueira N | |||
Kaplan G | |||
Sarno EN | |||
Gattass CR | |||
Horwitz MA | |||
Van Voorhis WC | |||
Hair LS | |||
P433 | issue | 26 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | leprosy | Q36956 |
P304 | page(s) | 1593-1597 | |
P577 | publication date | 1982-12-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes | |
P478 | volume | 307 |
Q37211779 | A journey in science: promise, purpose, privilege |
Q41815508 | A recombinant 64 kilodalton protein of Mycobacterium bovis bacillus Calmette-Guerin specifically stimulates human T4 clones reactive to mycobacterial antigens |
Q36350785 | An analysis of in vitro T cell responsiveness in lepromatous leprosy |
Q46508668 | Antigen-presenting cells in human cutaneous leishmaniasis due to Leishmania major |
Q72828077 | Appearance of T-Cell Subpopulations During the Time Course of Beryllium-Induced Granulomas |
Q41858984 | Atypical erythema nodosum leprosum as the presenting feature in multibacillary leprosy: a case report |
Q40168292 | Blood and tissue analysis of T-cell subsets in cutaneous diseases |
Q39728068 | Cell-mediated immunity in renal disease |
Q35410293 | Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals. |
Q42512070 | Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients |
Q33750104 | Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy. |
Q70948296 | Comparison of the effect of various stimuli on the leishmaniacidal capacity of human monocytes in vitro |
Q36993420 | Cutaneous host defense in leishmaniasis: interaction of isolated dermal macrophages and epidermal Langerhans cells with the insect-stage promastigote |
Q36348332 | Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2. |
Q44755558 | Defective intralesional interferon-gamma activity in patients with lepromatous leprosy. |
Q36348605 | Defective production of monocyte-activating cytokines in lepromatous leprosy |
Q42547923 | Detection of transforming growth factor-beta 1 in dermal lesions of different clinical forms of leprosy. |
Q34549608 | Differential dermal expression of CCL17 and CCL18 in tuberculoid and lepromatous leprosy. |
Q34797239 | Distinct regions of the large extracellular domain of tetraspanin CD9 are involved in the control of human multinucleated giant cell formation |
Q36352486 | Distribution and turnover of Langerhans cells during delayed immune responses in human skin |
Q44628778 | Dynamics of T cells of L3T4 and Ly 2 phenotype within granulomas in murine listeriosis |
Q33632725 | Efficacy of a cell-mediated reaction to the purified protein derivative of tuberculin in the disposal of Mycobacterium leprae from human skin |
Q39402156 | Evidence that the Mitsuda reaction to Mycobacterium leprae can be mediated by lymphocytes responsive to Mycobacterium tuberculosis. |
Q37140314 | Failure of immunosuppressive mechanisms in human Schistosoma mansoni infection with hepatosplenomegaly |
Q35818459 | Flow-cytometric evaluation of lymphocyte subpopulations in synchronously developing Schistosoma mansoni egg and Sephadex bead pulmonary granulomas. |
Q57081100 | Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions |
Q37172962 | Granulomatous inflammation--a review |
Q40189024 | Hansen's disease as a research model |
Q39535475 | Histometric study of the localisation of lymphocyte subsets and accessory cells in human Mantoux reactions |
Q72717389 | Host and Parasite Factors Affecting the Invasion of Mononuclear Phagocytes byTrypanosoma cruzi |
Q40165565 | Human T-cell clones with reactivity to Mycobacterium leprae as tools for the characterization of potential vaccines against leprosy |
Q69870765 | Human monocytes infected with Leishmania amastigotes enhance lymphocyte proliferation |
Q62733515 | IL-26 contributes to host defense against intracellular bacteria |
Q72819273 | Idiopathic acute interstitial nephritis: characterization of the infiltrating cells in the renal interstitium as T helper lymphocytes |
Q39185566 | Immune aspects of sarcoidosis |
Q36349058 | Immune cell populations in cutaneous delayed-type hypersensitivity. |
Q69492395 | Immunocytochemical analysis of cellular responses to BCG |
Q68962992 | Immunohistological characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon and in inflammatory bowel disease |
Q69895795 | Immunohistological phenotyping of thyroid infiltrating lymphocytes in Graves' disease and Hashimoto's thyroiditis |
Q43645411 | Immunologic findings in patients with an atypical course of an infection with non-typhoid salmonellae |
Q40111877 | Immunological Unresponsiveness in Leprosy |
Q39559385 | Immunopathology of leprosy granulomas |
Q40163989 | Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells |
Q68810869 | In situ characterization of T lymphocyte subpopulations in leprosy in the mangabey monkey |
Q72789612 | In situ characterization of T lymphocyte subsets in the reactional states of leprosy |
Q67294486 | In situ characterization of the cellular immune response in American cutaneous leishmaniasis |
Q70393302 | Infection with live mycobacteria inhibits in vitro detection of Ia antigen on macrophages |
Q35606253 | Influence of delayed immune reactions on human epidermal keratinocytes |
Q36489751 | Interactions between HIV infection and leprosy: a paradox |
Q70313049 | Intralesional T lymphocyte phenotypes and HLA-DR expression in Melkersson-Rosenthal syndrome |
Q33554190 | Learning from lesions: patterns of tissue inflammation in leprosy |
Q72785814 | Leprosy: Awakening the unresponsive lymphocyte |
Q38044386 | Leprosy: an overview of pathophysiology |
Q39482434 | Leprosy: new insight into an ancient disease |
Q26864057 | Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - part 1 |
Q36960935 | Limited clonal heterogeneity of antigen-specific T cells localizing in the pleural space during mycobacterial infection |
Q43478442 | Lymphocyte subpopulations in pyogranulomas of caseous lymphadenitis |
Q37099954 | Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy. |
Q72148706 | Mycobacterium leprae DNA content, cellular and cytokine patterns in skin lesions of leprosy patients undergoing multidrug therapy (MDT) |
Q35070041 | Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview |
Q68823014 | Phenotypic analyses of mononuclear cells recovered from healthy and diseased human periodontal tissues |
Q73026500 | Phenotypic characterisation of intestinal lymphocytes in ovine paratuberculosis by immunohistochemistry |
Q40812021 | Production of IL4 by human T cells and regulation of differentiation of T-cell subsets by IL4. |
Q68467307 | Quantitative pathology of coccidioidomycosis in acquired immunodeficiency syndrome |
Q43498839 | Regulation of macrophage accessory cell activity by mycobacteria. II. In vitro inhibition of Ia expression by Mycobacterium microti |
Q40472445 | Role of cytotoxic cells in the protective immunity against and immunopathology of intracellular infections |
Q38237905 | Role of endothelium in chronic inflammation |
Q42936592 | Specific antimononuclear phagocyte monoclonal antibodies. Application to the purification of dendritic cells and the tissue localization of macrophages |
Q40948359 | St. John Dermatological Society Oration, 1994. Immune responses in leprosy, cytokines and new archetypes for dermatology |
Q37048787 | Suppression of immune response to Listeria monocytogenes: mechanism(s) of immune complex suppression |
Q40116227 | Suppressor cell activity and phenotypes in the blood or tissues of patients with leprosy |
Q41970806 | Suppressor response in lepromatous leprosy patients: role of Leu 2a cells |
Q35427378 | T cell and cytokine patterns in leprosy skin lesions |
Q72799000 | T lymphocyte abnormalities in disseminated histoplasmosis |
Q36949806 | T-cell-mediated cytotoxicity against Mycobacterium antigen-pulsed autologous macrophages in leprosy patients |
Q36349012 | The cutaneous infiltrates of leprosy. A transmission electron microscopy study |
Q70015056 | The effects of Con A-induced lymphokines from the T-lymphocyte subpopulations on human monocyte leishmanicidal capacity and H2O2 production |
Q37176335 | The exanthem of Ross River virus infection: histology, location of virus antigen and nature of inflammatory infiltrate |
Q42209173 | The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin |
Q36356187 | The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2 |
Q40266934 | The mycobacterial secreted antigen 85 complex possesses epitopes that are differentially expressed in human leprosy lesions and Mycobacterium leprae-infected armadillo tissues |
Q42077823 | The nature and kinetics of a delayed immune response to purified protein derivative of tuberculin in the skin of lepromatous leprosy patients |
Q54458975 | Thymopentin treatment in patients with chemotherapy-resistant lepromatous leprosy. |
Q35876698 | Treatment of leprosy in the United States |
Q69535306 | Tuberculous pleural effusions: lymphocyte phenotypes in comparison with other lymphocyte-rich effusions |
Q40115012 | Why study T cell subsets in Crohn's disease? |
Search more.